I took a BIG position now in APHAI was in this company in and out from 2016 and know them well (the good, the bad and the ugly).
These current results are a temporary aberration from historical successes. A good entry point now for long term upside as the USA thesis of either decriminalization or legalization will raise most but not all Cannabis companies adn Tilray(Aphria) wil be among the winners. Certainly better than profligate spender Canopy (never had a positive EBITD) or perennial loser Aurora or Cronos.
The facilities in Leamington "(Listen to me" - I did not did not Leamingham) are world class and incomparable. Tilray and Aphria "to da moon".